← Leaderboards
Rikki Cannioto
Roswell Park Cancer Institute Corp
$273,498
Attributed
$473,495
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $386.7K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$473,495 · 2
By mechanism
R56$299,995 · 1
R03$173,500 · 1
Top collaborators
- Lauren Cole Peres1 shared
- Matthew B. Schabath1 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Wei Zheng$71,826,577
- Christine B. Ambrosone$40,409,261
- John David Carpten$9,472,293
- Xiang-Yang Wang$11,998,946
- Elizabeth Repasky$12,725,917
Others in their field
Other Rising Stars on “Recurrence”
- Erin Leahy · Icf, Inc., Llc$6,884,676
- Katherine Rivera-Spoljaric · Washington University$4,587,360
- Cindy S Chu · University Of Oxford$3,470,639
- Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr$3,395,194
- Toby Hecht · Leidos Biomedical Research, Inc.$3,323,184
- Talea Cornelius · Columbia University Health Sciences$3,273,481
Research focus
RecurrenceCancer SurvivalBiologicalTreatment ResponseDiagnosisWomanStandard Of CareWomen&AposCessation Of LifeCancer PreventionCell DensityAggressive Breast CancerAlcohol ConsumptionCellsClinically SignificantCancer SubtypesAnti-Cancer ResearchCancer RecurrenceBreast Cancer SurvivalAftercareCancer DiagnosisBiobankBreast Cancer PatientAmerican Cancer Society
Grant awards (3)
Linking lifestyles with tumor immune profiles to identify strategies for improving breast cancer outcomes$86,750
R03 · FY2025 · CA · contact PI
Radiomic biomarkers for clinical decision support that predict patient outcomes in serous ovarian carcinoma$299,995
R56 · FY2024 · CA
Linking lifestyles with tumor immune profiles to identify strategies for improving breast cancer outcomes$86,750
R03 · FY2024 · CA · contact PI